<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>9(5)</volume><submitter>Kapeleris J</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>Tumour tissue-based information is limited. Liquid biopsy can provide valuable real-time information through circulating tumour cells (CTCs). Profiling and expanding CTCs may provide avenues to study transient metastatic disease.&lt;h4>Methods&lt;/h4>Seventy non-small cell lung cancer (NSCLC) patients were recruited. CTCs were enriched using the spiral microfluidic chip and a RosetteSep™ using bloods from NSCLC patients. CTC cultures were carried out using the Clevers media under hypoxic conditions. CTCs were characterized using immunofluorescence and mutation-specific antibodies for samples with known mutation profiles. Exome sequencing was used to characterized CTC cultures.&lt;h4>Results&lt;/h4>CTCs (>2 cells) were detected in 38/70 (54.3%) of patients ranging from 0 to 385 CTCs </pubmed_abstract><journal>Translational lung cancer research</journal><pagination>1795-1809</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7653113</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>&lt;i>Ex vivo&lt;/i> culture of circulating tumour cells derived from non-small cell lung cancer.</pubmed_title><pmcid>PMC7653113</pmcid><pubmed_authors>Oleary C</pubmed_authors><pubmed_authors>Warkiani ME</pubmed_authors><pubmed_authors>Leo P</pubmed_authors><pubmed_authors>Punyadeera C</pubmed_authors><pubmed_authors>Kulasinghe A</pubmed_authors><pubmed_authors>Sternes P</pubmed_authors><pubmed_authors>O'Byrne K</pubmed_authors><pubmed_authors>Kapeleris J</pubmed_authors><pubmed_authors>Vela I</pubmed_authors></additional><is_claimable>false</is_claimable><name>&lt;i>Ex vivo&lt;/i> culture of circulating tumour cells derived from non-small cell lung cancer.</name><description>&lt;h4>Background&lt;/h4>Tumour tissue-based information is limited. Liquid biopsy can provide valuable real-time information through circulating tumour cells (CTCs). Profiling and expanding CTCs may provide avenues to study transient metastatic disease.&lt;h4>Methods&lt;/h4>Seventy non-small cell lung cancer (NSCLC) patients were recruited. CTCs were enriched using the spiral microfluidic chip and a RosetteSep™ using bloods from NSCLC patients. CTC cultures were carried out using the Clevers media under hypoxic conditions. CTCs were characterized using immunofluorescence and mutation-specific antibodies for samples with known mutation profiles. Exome sequencing was used to characterized CTC cultures.&lt;h4>Results&lt;/h4>CTCs (>2 cells) were detected in 38/70 (54.3%) of patients ranging from 0 to 385 CTCs </description><dates><release>2020-01-01T00:00:00Z</release><publication>2020 Oct</publication><modification>2025-04-04T23:46:22.886Z</modification><creation>2025-04-04T23:46:22.886Z</creation></dates><accession>S-EPMC7653113</accession><cross_references><pubmed>33209602</pubmed><doi>10.21037/tlcr-20-521</doi></cross_references></HashMap>